EUVIMEDEUVIMED entdecken
Crossref

Oral Tofacitinib for the Management of Moderate to Severe Alopecia Areata in Children and Adolescents: A Retrospective Study of 36 Patients

Rahul Mahajan iD, Hitaishi Mehta iD, Dipankar De, Sanjeev Handa

Pediatric Dermatology · 2025-07 · 42 (4) · 796-799

DOI: 10.1111/pde.15882 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Dermatology, online erschienen am 06.02.2025. Verfasst von Rahul Mahajan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Venereology and Leprology, Post Graduate Institute of Medical Education and Research, Chandigarh, India. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 9 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Oral tofacitinib shows promise for pediatric alopecia areata (AA), but more data on its efficacy and safety are needed.

Methods

We analyzed 36 patients aged ≤ 16 years with moderate to severe AA (SALT score > 20) who received at least 6 months of oral tofacitinib.

Results

SALT75 was achieved in 72.2% (26/36) and SALT100 in 52.8% (19/36) within 4.1 ± 1.7 and 6.7 ± 2.8 months, respectively; 27.8% (10/36) were non‐responders. Nine patients had adverse events, with two requiring treatment discontinuation.

Conclusion

Tofacitinib is effective for pediatric AA, with rapid regrowth in responders. The durability of benefit and need for long term maintenance therapy require further investigation.

Schlagwörter

Stichwörter der Autor:innen

alopeciaalopecia areatapediatric alopecia areatareal‐world studytofacitinib

Autor:innen und Institutionen

  • Department of Dermatology, Venereology and Leprology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

ORCID-Profile: Rahul Mahajan, Hitaishi Mehta

Zitieren

APA

Mahajan, R., Mehta, H., De, D., & Handa, S. (2025). Oral Tofacitinib for the Management of Moderate to Severe Alopecia Areata in Children and Adolescents: A Retrospective Study of 36 Patients. Pediatric Dermatology, 42(4), 796-799. https://doi.org/10.1111/pde.15882

Vancouver

Mahajan R, Mehta H, De D, Handa S. Oral Tofacitinib for the Management of Moderate to Severe Alopecia Areata in Children and Adolescents: A Retrospective Study of 36 Patients. Pediatric Dermatology. 2025;42(4):796-799. doi:10.1111/pde.15882

BibTeX
@article{Mahajan2025,
  author = {Mahajan, Rahul and Mehta, Hitaishi and De, Dipankar and Handa, Sanjeev},
  title = {Oral Tofacitinib for the Management of Moderate to Severe Alopecia Areata in Children and Adolescents: A Retrospective Study of 36 Patients},
  journal = {Pediatric Dermatology},
  year = {2025},
  volume = {42},
  number = {4},
  pages = {796--799},
  doi = {10.1111/pde.15882}
}
Kostenlos starten →